| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Jason I Herschkowitz | Q92188349 |
| P2093 | author name string | Rebecca S DeVaux | |
| P2860 | cites work | Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer. | Q53262835 |
| Promoter CpG island hypermethylation during breast cancer progression. | Q53449089 | ||
| Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue | Q57591075 | ||
| Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression | Q77916758 | ||
| Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways | Q77976506 | ||
| Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues | Q83161784 | ||
| LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway | Q38757707 | ||
| Epigenetic regulators: Polycomb-miRNA circuits in cancer | Q38774454 | ||
| Molecular and Cellular Changes in Breast Cancer and New Roles of lncRNAs in Breast Cancer Initiation and Progression | Q38793289 | ||
| The molecular hallmarks of epigenetic control | Q38877902 | ||
| Bromodomain inhibitors and cancer therapy: From structures to applications | Q39027056 | ||
| Functions of bromodomain-containing proteins and their roles in homeostasis and cancer. | Q39067631 | ||
| Regulation of inducible and tissue-specific gene expression | Q39656942 | ||
| Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers | Q39723644 | ||
| NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS). | Q39943915 | ||
| Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells. | Q40838927 | ||
| Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo | Q41455736 | ||
| Xenograft model of progressive human proliferative breast disease | Q41514873 | ||
| The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence | Q42277468 | ||
| Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. | Q42452150 | ||
| Ductal carcinoma in situ: a rose by any other name | Q42676027 | ||
| Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors | Q45877410 | ||
| Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis | Q46382065 | ||
| BC200 RNA in invasive and preinvasive breast cancer | Q47233113 | ||
| miRNAs as Biomarkers for Predicting the Progression of Ductal Carcinoma in Situ | Q47778954 | ||
| Enhancer-associated long non-coding RNA LEENE regulates endothelial nitric oxide synthase and endothelial function | Q48215015 | ||
| Functional Classification and Experimental Dissection of Long Noncoding RNAs | Q49649796 | ||
| Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine. | Q50021169 | ||
| CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis. | Q50044853 | ||
| Epigenetic alterations to Polycomb targets precede malignant transition in a mouse model of breast cancer. | Q52332848 | ||
| Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. | Q52832871 | ||
| MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. | Q52832877 | ||
| Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis. | Q53148930 | ||
| The Polycomb group protein EZH2 directly controls DNA methylation | Q24299020 | ||
| Selective inhibition of BET bromodomains | Q24301009 | ||
| A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis | Q24322334 | ||
| Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis | Q24607308 | ||
| MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype | Q24646090 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells | Q24672969 | ||
| LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer | Q26799778 | ||
| MicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to Therapy | Q26801487 | ||
| Enhancer RNAs and regulated transcriptional programs | Q26865277 | ||
| Regulation of mammary epithelial cell homeostasis by lncRNAs | Q27011533 | ||
| Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans | Q27860584 | ||
| The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
| The language of covalent histone modifications | Q27860931 | ||
| The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 | Q27861068 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| Tumour invasion and metastasis initiated by microRNA-10b in breast cancer | Q28131829 | ||
| Targeting bromodomains: epigenetic readers of lysine acetylation | Q28238635 | ||
| BET bromodomain inhibition as a therapeutic strategy to target c-Myc | Q28247024 | ||
| Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA | Q28259224 | ||
| DNA Methylation and Gene Function | Q28263722 | ||
| Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology | Q28269080 | ||
| A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p | Q28276243 | ||
| Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence | Q28277232 | ||
| Overdiagnosis and overtreatment in cancer: an opportunity for improvement | Q28295529 | ||
| CpG islands and the regulation of transcription | Q28315762 | ||
| Super-enhancers in the control of cell identity and disease | Q28661442 | ||
| The Polycomb complex PRC2 and its mark in life | Q29547358 | ||
| A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression | Q29614326 | ||
| Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10 | Q29615921 | ||
| Selective inhibition of tumor oncogenes by disruption of super-enhancers | Q29617301 | ||
| Endogenous human microRNAs that suppress breast cancer metastasis | Q29617352 | ||
| Master transcription factors and mediator establish super-enhancers at key cell identity genes | Q29618062 | ||
| Quantitative assessment of promoter hypermethylation during breast cancer development | Q30811494 | ||
| Proteomics of human breast ductal carcinoma in situ. | Q30870715 | ||
| Molecular markers in ductal carcinoma in situ of the breast. | Q31135997 | ||
| Gene expression profiles of human breast cancer progression | Q33186821 | ||
| Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis | Q33243821 | ||
| Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines | Q33532630 | ||
| Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus | Q33571385 | ||
| Genomic organization of microRNAs | Q33640180 | ||
| Nucleosome positioning and histone modifications define relationships between regulatory elements and nearby gene expression in breast epithelial cells | Q33669183 | ||
| Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer | Q33837404 | ||
| DNA hypomethylation in cancer cells | Q33862334 | ||
| Enhancers as non-coding RNA transcription units: recent insights and future perspectives | Q34046402 | ||
| Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression | Q34088777 | ||
| MicroRNA sequence and expression analysis in breast tumors by deep sequencing | Q34185623 | ||
| Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis | Q34196315 | ||
| DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma | Q34274795 | ||
| Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma | Q34362028 | ||
| Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast | Q34392800 | ||
| Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element | Q34447771 | ||
| Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*. | Q34452272 | ||
| Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers | Q34468271 | ||
| Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement | Q34508652 | ||
| miRBase: the microRNA sequence database | Q34564134 | ||
| An atlas of active enhancers across human cell types and tissues | Q34660689 | ||
| Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression | Q34693969 | ||
| Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. | Q34694010 | ||
| Assessment of DNA methylation status in early stages of breast cancer development | Q34709370 | ||
| Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast | Q34779627 | ||
| The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. | Q34888585 | ||
| Histone modifications dictate specific biological readouts | Q34949462 | ||
| lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. | Q35108871 | ||
| Coordinated regulation of polycomb group complexes through microRNAs in cancer. | Q35167450 | ||
| Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression | Q35636561 | ||
| The 5-methylcytosine content of DNA from human tumors | Q35689206 | ||
| Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. | Q35860815 | ||
| DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer | Q35888926 | ||
| Macrophage infiltration promotes invasiveness of breast cancer cells via activating long non-coding RNA UCA1. | Q36095147 | ||
| Control of Chromatin Structure by Long Noncoding RNA. | Q36096797 | ||
| Breast cancer: origins and evolution | Q36099434 | ||
| Translational control at the synapse: role of RNA regulators | Q36488134 | ||
| DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer | Q36540420 | ||
| Braveheart, a long noncoding RNA required for cardiovascular lineage commitment | Q36585810 | ||
| A Molecular Portrait of High-Grade Ductal Carcinoma In Situ | Q36622366 | ||
| Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex | Q36783309 | ||
| Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer | Q36862936 | ||
| Targeting MYCN in neuroblastoma by BET bromodomain inhibition | Q36903802 | ||
| Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression | Q37102942 | ||
| Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors | Q37190152 | ||
| Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer | Q37205583 | ||
| Regulating the regulators: mechanisms controlling the maturation of microRNAs. | Q37326890 | ||
| Dicer1 functions as a haploinsufficient tumor suppressor | Q37457958 | ||
| Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer | Q37507568 | ||
| Molecular Markers for the Diagnosis and Management of Ductal Carcinoma In Situ | Q37509551 | ||
| New roles of flavoproteins in molecular cell biology: histone demethylase LSD1 and chromatin | Q37558687 | ||
| Erasers of histone acetylation: the histone deacetylase enzymes | Q37673993 | ||
| Breast cancer precursors revisited: molecular features and progression pathways | Q37760539 | ||
| Histone core modifications regulating nucleosome structure and dynamics | Q38260208 | ||
| Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics | Q38318356 | ||
| Long noncoding RNAs in cardiac development and ageing | Q38412337 | ||
| Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci | Q38472116 | ||
| Pervasive lncRNA binding by epigenetic modifying complexes--The challenges ahead | Q38606323 | ||
| Unique features of long non-coding RNA biogenesis and function | Q38668939 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast neoplasm | Q23929670 |
| genetic epigenesis | Q64443099 | ||
| P304 | page(s) | 223-235 | |
| P577 | publication date | 2018-10-10 | |
| 2018-12-01 | |||
| P1433 | published in | Journal of Mammary Gland Biology and Neoplasia | Q15724460 |
| P1476 | title | Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer | |
| P478 | volume | 23 |
| Q64940251 | DNA Methylation Profiles and Their Diagnostic Utility in BC. |
| Q92702483 | Epigenetic Dysregulation at the Crossroad of Women's Cancer |
| Q90397112 | Flavonoids and Other Polyphenols Act as Epigenetic Modifiers in Breast Cancer |
| Q64117893 | The function of histone acetylation in cervical cancer development |
Search more.